APCIS SA - Export company showcase @ B2B French Export Directory

APcis is a preclinical CRO. Focussing on predictive animal models, with a total dedication to the 3 Rs policy of reduction refinement and replacement methods the company has developed new models allowing to speed up the development of new drug candidates and to increase the success rate from Phase I to phase III in man.
Infectious diseases: with more than 50 models in rodents, APcis is able to screen and validate targets for new antivirals, antibacterial and antifungal candidates.
Cancer: solid human tumours and homospecific cell lines are followed over time with non invasive ultra high definition and high speed CT scans. Our new methods allow to
Central Nervous System: from 5HT2 KO mice to dog models, APcis has unique insight on sleep and depression analysis.
New imaging techniques, humane models, biochemical pathways and PK-PD techniques in high tech environment.

Legal Name	APCIS SA
Director Name	TAFANI Jean-Pierre
French Legal Category	Limited liability company with board of directors
Registered capital (in Euros)	70 400
Year company founded
Etablishment legal status	Limited liability company with board of directors
% Turnover from export	unknown
Related activities	Health, pharmacy, life sciences Biotechnology Pharmacy

> French-Business-Home > Company : APCIS SA